18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Merck & Co A0YD8Q NYSE 132,190 26.06.24 21:06:52 -0,730 -0,55% 132,190 132,200 133,140 132,920
Ligand Pharmaceuticals A1C9RN NASDAQ 77,945 26.06.24 21:05:12 -0,955 -1,21% 77,860 78,180 78,450 78,900

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH